Galeanu Mihai The U.S. Dollar Index (DXY) and U.S. Treasury yields fell for the second consecutive week following the release of softer-than-expected Consumer Price Index (CPI) data. The US dollar index (DXY) slipped 0.75% after softer inflation numbers increased the odds of a September interest rate cut by the Fed.Continue Reading
Gam1983/iStock via Getty Images Eli Lilly (NYSE:LLY) is the weight loss drug stock with the most potential for upside, according to Seeking Alpha’s July Sentiment Survey. July’s Sentiment Survey by Seeking Alpha is out, covering what’s hot in the markets, the economy and other current themes. According to the survey,Continue Reading
Manchester United (NYSE:MANU) reported a wider third-quarter loss on Wednesday as the English soccer club tackled surging operating expenses and saw segment revenues decline sharply from last year. For the full year, the club expects to generate revenue of about £660 million, revised from the previously provided forecast range ofContinue Reading
ArLawKa AungTun/iStock via Getty Images Large real estate stocks kicked off the second half of 2024 with a marginal weekly loss despite the optimism surrounding rate cuts, as the state of the sector weighed on sentiment. S&P 500 advanced 1.95% from last week, with the labor market data supporting theContinue Reading
zhaojiankang/iStock via Getty Images ArcelorMittal (NYSE:MT) said Tuesday it has decided against shutting its Newcastle steel plant in South Africa and is working on a plan to make it viable, more than six months after announcing its closure. The plant in KwaZulu-Natal province makes fencing material, rail, rods and barsContinue Reading
SlavkoSereda/iStock via Getty Images Crude oil futures closed the week and the month with gains as expectations rose for summer demand to continue the rally. Oil had tumbled to multi-month lows early in June when OPEC+ said it would start unwinding production cuts after September, then rallied on forecasts ofContinue Reading
ShinjiPhotographer/iStock via Getty Images Interactive Brokers (NASDAQ:IBKR) incurred a loss of ~$48M related to a technical issue at the New York Stock Exchange on June 3, 2024, that had indicated that Berkshire Hathaway (NYSE:BRK.A) class A shares had plunged to ~$185 per share from ~$622K in a space of aContinue Reading
Suriyawut Suriya/iStock via Getty Images Taking Novo Nordisk’s older GLP-1 medication Saxenda (liraglutide) while regularly exercising led to maintaining bone mineral density (BMD) while losing weight, according to a new study. Researchers conducted a secondary analysis of a randomized clinical trial of 195 obese adults. Results showed that exercise andContinue Reading
CR Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO), which already have blockbusters with their weight loss drugs Zepbound (tirzepatide) and Wegovy (tirzepatide), are likely to dominate the market even if other drugs are approved, according to two Street analysts. Holly Morris, managing director at J.P. Morgan Asset Management focused onContinue Reading
